Cleared Traditional

K260525 - NextMR Spine

K260525 is an FDA 510(k) clearance for NextMR Spine, manufactured by MRI2CT, Inc.. The device is a Class 2 Radiology device with product code QIH cleared through the Traditional 510(k) pathway after a 199-day FDA review.

K260525 · MRI2CT, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2026
Decision
199d
Days
Class 2
Risk

K260525 is an FDA 510(k) clearance for the NextMR Spine. Classified as Automated Radiological Image Processing Software within the QIH classification (a category dominated by AI-based automated radiology processing systems), Class II - Special Controls.

Submitted by MRI2CT, Inc. (Claymont, US). The FDA issued a Cleared decision on September 4, 2026 after a review of 199 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all MRI2CT, Inc. devices

FDA 510(k) Submission Details - K260525

510(k) Number K260525 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 17, 2026
Decision Date September 04, 2026
Days to Decision 199 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
92d slower than avg
Panel avg: 107d · This submission: 199d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

QIH Device Classification - Class 2, Special Controls

Product Code QIH Automated Radiological Image Processing Software
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
Definition To Provide Automated Radiological Image Processing And Analysis Tools. Software Implementing Artificial Intelligence Including Nonadaptive Machine Learning Algorithms Trained With Clinical And/or Artificial Data. In These Devices, The Algorithm Training Data Typically Impacts Device Performance. Adaptive Ai Algorithms Are Not Within Scope Of This Product Code.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Dalia Givony, Regulatory & Clinical Consulting
Dalia Givony

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - QIH Automated Radiological Image Processing Software

All 329
Devices cleared under the same product code (QIH) and FDA review panel - the closest regulatory comparables to K260525.
4DM
K260879 · INVIA, LLC · Sep 2026
Quicktome Software Suite
K261795 · Omniscient Neurotechnology Pty, Ltd. · Sep 2026
ReVISION 2
K251417 · Argus Cognitive, Inc. · Sep 2026
Heartvue.Proton
K260811 · Heartvue.ai, Inc. · Aug 2026
Ceevra Reveal 4
K261595 · Ceevra, Inc. · Aug 2026
BoneMRI
K260584 · Mriguidance B.V. · Aug 2026